These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2864394)

  • 61. Local and distant neuronal degeneration following intrastriatal injection of kainic acid.
    Zaczek R; Simonton S; Coyle JT
    J Neuropathol Exp Neurol; 1980 May; 39(3):245-64. PubMed ID: 6154134
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evidence for the presence of somatostatin 28 in plasma.
    Shoelson S; Polonsky K; Docherty H; Jaspan J; Rubenstein A
    Diabetes; 1982 May; 31(5 Pt 1):474-7. PubMed ID: 6130021
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Processing of an anglerfish somatostatin precursor to a hydroxylysine-containing somatostatin 28.
    Spiess J; Noe BD
    Proc Natl Acad Sci U S A; 1985 Jan; 82(2):277-81. PubMed ID: 2857489
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differential changes in mRNAs encoding for preprotachykinin A and B after kainic acid-induced seizures in the rat.
    Bellmann R; Humpel C; Krause JE; Marksteiner J; Saria A; Sperk G
    Synapse; 1991 May; 8(1):71-3. PubMed ID: 1871681
    [No Abstract]   [Full Text] [Related]  

  • 65. Somatostatin-28 is an hormonally active peptide secreted into hypophysial portal vessel blood.
    Millar RP; Sheward WJ; Wegener I; Fink G
    Brain Res; 1983 Feb; 260(2):334-7. PubMed ID: 6131728
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vivo synthesis and processing of rat hypothalamic prosomatostatin.
    Camier M; Barre N; Morel A; Cohen P
    FEBS Lett; 1986 Feb; 196(1):14-8. PubMed ID: 2867937
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of cysteamine on levels of somatostatin-like immunoreactivity and catecholamines and on electroencephalogram in the rat brain.
    Pitkänen A; Valjakka A; Pääkkönen A; Sirviö J; Jousmäki V; Partanen J; Riekkinen PJ
    Neuropeptides; 1989 Jul; 14(1):1-9. PubMed ID: 2571105
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparison of regional somatostatin and neuropeptide Y distribution in rat striatum and brain.
    Beal MF; Chattha GK; Martin JB
    Brain Res; 1986 Jul; 377(2):240-5. PubMed ID: 3755369
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterisation of somatostatin and TRH release by rat hypothalamic and cerebral cortical neurons maintained on a capillary membrane perfusion system.
    Scanlon MF; Robbins RJ; Bolaffi JL; Jackson IM; Reichlin S
    Neuroendocrinology; 1983 Oct; 37(4):269-74. PubMed ID: 6138723
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ultrastructural evaluation of the damage of postsynaptic elements after kainic acid injection into the rat neostriatum.
    Matyja E
    J Neurosci Res; 1986; 15(3):405-13. PubMed ID: 3701889
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Release of D-[3H]aspartic acid from the rat striatum. Effect of veratridine-evoked depolarization, fronto-parietal cortex ablation, and striatal lesions with kainic acid.
    Arqueros L; Abarca J; Bustos G
    Biochem Pharmacol; 1985 Apr; 34(8):1217-24. PubMed ID: 2581579
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glucose-induced changes in somatostatin-14 and somatostatin-28 released from rat hypothalamic fragments 'in vitro'.
    Lengyel AM; Nieuwenhuyzen Kruseman AC; Grossman A; Rees LH; Besser GM
    Life Sci; 1984 Aug; 35(7):713-9. PubMed ID: 6147741
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Processing of somatostatin-28 to somatostatin-14 by rat hypothalamic synaptosomal membranes.
    Zingg HH; Patel YC
    Life Sci; 1983 Sep; 33(13):1241-7. PubMed ID: 6136883
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hypersomatostatinemia in chronic renal failure.
    Wasada T; Inoue K; Fujimi S; Sako Y; Hisatomi A; Ibayashi H
    Endocrinol Jpn; 1987 Apr; 34(2):251-6. PubMed ID: 2887424
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Heterogeneity of somatostatin like immunoreactivity (SLI) in extracts of porcine, canine and human pancreas.
    Newgard CB; Holst JJ
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):564-72. PubMed ID: 6118002
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Origin and characterization of immunoreactive somatostatin in rat pure pancreatic juice.
    Sarfati P; Morisset J
    Pancreas; 1990 Mar; 5(2):158-64. PubMed ID: 1969158
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 2-Chloroadenosine prevents kainic acid-induced toxicity in rat striatum.
    Arvin B; Neville LF; Roberts PJ
    Neurosci Lett; 1988 Nov; 93(2-3):336-40. PubMed ID: 3241658
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of somatostatin in peripheral and portal plasma in the duck: in-vivo metabolism of somatostatin-28 and -14.
    Di Scala-Guenot D; Strosser MT; Mialhe P
    J Endocrinol; 1984 Mar; 100(3):329-35. PubMed ID: 6142074
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunoreactive somatostatin-28(1-12) is increased in Huntington's disease.
    Beal MF; Benoit R; Bird ED; Martin JB
    Neurosci Lett; 1985 May; 56(3):377-80. PubMed ID: 2862613
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of gastric somatostatin-like immunoreactivity in response to corticosterone acetate and dietary changes in young rats.
    Okahata H; Nishi Y; Muraki K; Sumii K; Miyachi Y; Ueda K
    Acta Endocrinol (Copenh); 1986 Jul; 112(3):383-7. PubMed ID: 3751455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.